K. N. Pılancı Et Al. , "Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?," MEDICINE , vol.94, 2015
Pılancı, K. N. Et Al. 2015. Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?. MEDICINE , vol.94 .
Pılancı, K. N., Alco, G., Ordu, C., Sarsenov, D., Celebı, F., Erdogan, Z., ... Agacayak, F.(2015). Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?. MEDICINE , vol.94.
Pılancı, Kezban Et Al. "Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?," MEDICINE , vol.94, 2015
Pılancı, Kezban N. Et Al. "Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?." MEDICINE , vol.94, 2015
Pılancı, K. N. Et Al. (2015) . "Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?." MEDICINE , vol.94.
@article{article, author={Kezban Nur PİLANCI Et Al. }, title={Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?}, journal={MEDICINE}, year=2015}